<DOC>
	<DOCNO>NCT00874887</DOCNO>
	<brief_summary>The purpose study assess presence BAK fluoroquinolone study eye affect development resistant bacteria conjunctiva base upon change surface flora course 2 week topical treatment healthy adult subject .</brief_summary>
	<brief_title>A Clinical Study Evaluate Benzalkonium Chloride ( BAK ) Quinolone Eyedrop Reduces Likelihood Developing Resistant Organisms</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Benzalkonium Compounds</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Male Female At least 50 year age In good general health Any ocular surgery use topical antibiotic antiseptic either eye within last 3 month Use topical steroid , nonsteroidal anti inflammatory drug either eye within 30 day Baseline ( anticipate study ) Use lid scrub within 7 day Baseline either eye ( anticipate use study )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>